Trial Profile
Cardiac safety of laquinimod in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Laquinimod (Primary) ; Moxifloxacin
- Indications Crohn's disease; Huntington's disease; Multiple sclerosis
- Focus Adverse reactions
- 18 Feb 2016 New trial record